MAPK3 and breast carcinoma: Taken together, data in Figure 5 show that α-TEA can downregulate the basal levels of active AKT, ERK1/2, and mTOR, and can act cooperatively with either chemical- or genetic-based inhibitors of these prosurvival mediators to enhance breast cancer cell death.